As Askbio acquires Brainvectis, Erganeo’s first start-up flies the nest
On 17 April, Brainvectis, a start-up supported by Erganeo specialising in neurodegenerative disease treatments, was acquired by American company Asklepios BioPharmaceutical (AskBio).
